When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. AstraZeneca withdraws Covid-19 vaccine, citing low demand - AOL

   www.aol.com/astrazeneca-withdraws-covid-19...

   The vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been one of the main Covid-19 vaccines worldwide, with more than 3 billion doses supplied since ...

3. AstraZeneca to withdraw COVID vaccine globally as ... - AOL

   www.aol.com/news/astrazeneca-withdraw-covid-19...

   The Serum Institute of India (SII), which produced AstraZeneca's COVID-19 vaccine under ... AstraZeneca to withdraw COVID vaccine globally as demand dips. May 8, 2024 at 6:12 AM

4. Oxford–AstraZeneca COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID...

   A study on the effectiveness of a first dose of the Pfizer–BioNTech or Oxford–AstraZeneca COVID-19 vaccines against COVID-19 related hospitalisation in Scotland was based on a national prospective cohort study of 5.4 million people. Between 8 December 2020 and 15 February 2021, 1,137,775 participants were vaccinated in the study, 490,000 of ...

5. List of COVID-19 vaccine authorizations - Wikipedia

   en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

   The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria [6] and Covishield, [7] is a viral vector vaccine [8] produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations.

6. How Europe soured on the AstraZeneca vaccine - AOL

   www.aol.com/news/europe-soured-astrazeneca...

   Anthony Fauci made waves in November, saying AstraZeneca’s vaccine presented a dilemma: While preliminary studies showed the Pfizer and Moderna vaccines provided protection against COVID-19 by ...

7. European Commission–AstraZeneca COVID-19 vaccine dispute

   en.wikipedia.org/wiki/European_Commission...

   A packet of AstraZeneca COVID-19 vaccine vials. A dispute broke out in January 2021 between the European Commission and the pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, [1] and, in February, spilled out into a dispute over Article 16 of the Northern Ireland Protocol.

8. US: AstraZeneca may have used outdated info in vaccine trial

   www.aol.com/us-astrazeneca-may-used-outdated...

   Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have included “outdated information” and that could mean the company provided an incomplete view of efficacy data, American ...

9. Embolic and thrombotic events after COVID-19 vaccination

   en.wikipedia.org/wiki/Embolic_and_thrombotic...

   A number of COVID‑19 vaccines began to become approved and available at scale in December 2020, with vaccinations beginning to ramp up at scale from the beginning of 2021, among them the Oxford–AstraZeneca COVID‑19 vaccine, based on an adenovirus vector and internally termed AZD1222. [citation needed]